Search

Author/Creator Hallmeyer, Sigrun

11. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte‐macrophage colony‐stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. Issue 12 (13th July 2016)

Authors:
Andtbacka, Robert H. I.; Agarwala, Sanjiv S.; Ollila, David W.; Hallmeyer, Sigrun; Milhem, Mohammed; Amatruda, Thomas; Nemunaitis, John J.; Harrington, Kevin J.; Chen, Lisa; Shilkrut, Mark; Ross, Merrick; Kaufman, Howard L.
Journal:
Head & neck
Issue:
Volume 38:Issue 12(2016)
Page Start:
1752
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02). (6th November 2014)

Authors:
Patel, Sapna; Milhem, Mohammed; Hallmeyer, Sigrun; Daniels, Gregory; Cranmer, Lee; Taback, Bret; Flaherty, Lawrence; Aung, Sandra; Lowder, James; Sharfman, William
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. Issue 24 (20th August 2021)

Authors:
Olson, Daniel J.; Eroglu, Zeynep; Brockstein, Bruce; Poklepovic, Andrew S.; Bajaj, Madhuri; Babu, Sunil; Hallmeyer, Sigrun; Velasco, Mario; Lutzky, Jose; Higgs, Emily; Bao, Riyue; Carll, Timothy C.; Labadie, Brian; Krausz, Thomas; Zha, Yuanyuan; Karrison, Theodore; Sondak, Vernon K.; Gajewski, Th...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 24(2021)
Page Start:
2647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. (4th November 2015)

Authors:
Andtbacka, Robert HI; Curti, Brendan D; Hallmeyer, Sigrun; Feng, Zipei; Paustian, Christopher; Bifulco, Carlo; Fox, Bernard; Grose, Mark; Shafren, Darren
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. Issue 2 (December 2015)

Authors:
Andtbacka, Robert; Curti, Brendan; Hallmeyer, Sigrun; Feng, Zipei; Paustian, Christopher; Bifulco, Carlo; Fox, Bernard; Grose, Mark; Shafren, Darren
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Real‐world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study. (26th April 2016)

Authors:
Middleton, Mark R.; Dalle, Stéphane; Claveau, Joel; Mut, Pilar; Hallmeyer, Sigrun; Plantin, Patrice; Highley, Martin; Kotapati, Srividya; Le, Trong Kim; Brokaw, Jane; Abernethy, Amy P.
Journal:
Cancer medicine
Issue:
Volume 5:Number 7(2016:Jul.)
Page Start:
1436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update. Issue 7 (1st March 2022)

Authors:
Eisen, Andrea; Somerfield, Mark R.; Accordino, Melissa K.; Blanchette, Phillip S.; Clemons, Mark J.; Dhesy-Thind, Sukhbinder; Dillmon, Melissa S.; D'Oronzo, Stella; Fletcher, Glenn G.; Frank, Elizabeth S.; Hallmeyer, Sigrun; Makhoul, Issam; Moy, Beverly; Thawer, Alia; Wu, Joy Y.; Van Poznak, Cath...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 7(2022)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E. Issue 6 (December 2017)

Authors:
Hallmeyer, Sigrun; Gonzalez, Rene; Lawson, David H.; Cranmer, Lee D.; Linette, Gerald P.; Puzanov, Igor; Taback, Bret; Cowey, C. Lance; Ribas, Antoni; Daniels, Gregory A.; Moore, Timothy; Gibney, Geoffrey T.; Tawbi, Hussein; Whitman, Eric; Lee, Geraldine; Mun, Yong; Liu, Shiyao; Hamid, Omid
Journal:
Melanoma research
Issue:
Volume 27:Issue 6(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗